Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa
Br J Dermatol
.
2020 Jan;182(1):240-242.
doi: 10.1111/bjd.18335.
Epub 2019 Sep 17.
Authors
N Goldfarb
1
2
,
J R Ingram
3
,
G B E Jemec
4
5
,
H B Naik
6
,
V Piguet
7
,
M J Hyde
8
,
R Freese
9
,
M A Lowes
8
,
A Alavi
7
Affiliations
1
Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN, U.S.A.
2
Departments of Medicine and Dermatology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, U.S.A.
3
Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, U.K.
4
Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
5
Department of Dermatology, University of Copenhagen, Copenhagen, Denmark.
6
Department of Dermatology, University of California San Francisco, San Francisco, CA, U.S.A.
7
Department of Medicine, Division of Dermatology, Women's College Hospital, University of Toronto, Toronto, ON, Canada.
8
The Rockefeller University, New York, NY, U.S.A.
9
Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, U.S.A.
PMID:
31286486
PMCID:
PMC7769071
DOI:
10.1111/bjd.18335
No abstract available
Publication types
Letter
MeSH terms
Hidradenitis Suppurativa* / diagnosis
Humans
Pilot Projects
Severity of Illness Index
Grants and funding
UL1 TR002494/TR/NCATS NIH HHS/United States